Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125244281 | 12524428 | 1 | I | 2015 | 20160620 | 20160704 | 20160704 | EXP | DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119632 | RANBAXY | 55.00 | YR | F | Y | 65.00000 | KG | 20160704 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125244281 | 12524428 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 500 MG, BID | U | U | 75747 | 500 | MG | Q12H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125244281 | 12524428 | 1 | Cystitis noninfective |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125244281 | 12524428 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125244281 | 12524428 | Arthritis | |
| 125244281 | 12524428 | Myositis | |
| 125244281 | 12524428 | Neuritis | |
| 125244281 | 12524428 | Tendonitis | |
| 125244281 | 12524428 | Vascular injury | |
| 125244281 | 12524428 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125244281 | 12524428 | 1 | 2015 | 0 |